Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BF.14EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BF.14EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.14ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BF.14ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BF.14EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BF.14EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BF.14ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BF.14ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CK.2.1.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
CK.2.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CK.2.1.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
CK.2.1.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
CK.2.1.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
CK.2.1.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
CK.2.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CK.2.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EE.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
EE.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EE.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
EE.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
EE.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
EE.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
EE.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
EE.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
DB.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
DB.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DB.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
DB.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
DB.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
DB.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
DB.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
DB.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EF.1.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
EF.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EF.1.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
EF.1.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
EF.1.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
EF.1.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
EF.1.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
EF.1.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BU.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BU.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BU.3ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BU.3ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BU.3EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BU.3EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BU.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BU.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.1.38EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.5.1.38EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used